Feed NAOV
NA

NanoVibronix, Inc.

NAOV · NASDAQ

$1.90 +1.06% (+$0.02)
Piotroski F-Score Weak
0/9
Valuation
-
N/A
P/B N/A
EV/FFO N/A
P/E N/A
Growth
-
N/A
Book val. growth N/A
FCF growth N/A
EPS growth N/A
Profitability
-
N/A
FCF margin N/A
Op. margin N/A
Gross margin N/A
Quality
-
N/A
Asset turnover N/A
ROA N/A
ROIC N/A
Debt
-
N/A
Net debt/EBITDA N/A
Int. coverage N/A
Debt/Equity N/A
Stability
0 /100
Unstable
Beta 2.06x
EPS volatility N/A
Profitable years N/A

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about NAOV
Online

About the company

NanoVibronix (NVCN) is a company focused on the development and commercialization of innovative medical devices utilizing ultrasound technology. With a product portfolio including PainShield®, NanoVibronix is a pioneer in the field of ultrasound therapy for the treatment of various conditions and ailments. PainShield® is a portable device designed to treat pain and inflammation using ultrasound vibrations applied to the affected area. The company also focuses on other applications of ultrasound technology in areas such as regenerative therapies, drainage procedures, and infection prevention. With growing interest in non-invasive therapeutic methods and the need for innovative treatment approaches, NanoVibronix has the potential for further development and expansion in the market. NanoVibronix (NVCN) shares could be suitable for investors seeking exposure in the medical technology field with a focus on ultrasound therapy and innovative treatment approaches.

Sector

Healthcare

Industry

Medical - Devices

CEO

Doron Robert Besser

Employees

31

Headquarters

Elmsford

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.